We hypothesize that CD34+CD38− cells with aberrant immunophenotypes play a critical role in leukemogenesis based on the relationship between the presence of IA-HSCs and leukemic transformation in MDS patients. This evidence concerns the gene CD38 and myelodysplastic syndrome.